Metastable Tolerance to Rhesus Monkey Renal Transplants Is Correlated with Allograft TGF-β1+CD4+ T Regulatory Cell Infiltrates

Journal of Immunology

Volumn 172, Issue 9, 2004, Pages 5753-5764

  Torrealba, Jose R ^a   Katayama, Masaaki ^b   Fechner Jr , John H ^b   Jankowska Gan, Ewa ^b   Kusaka, Satoshi ^b   Xu, Qingyong ^b   Schultz, Jacqueline M ^b   Oberley, Terry D ^a   Hu, Huaizhong ^b   Hamawy, Majed M ^b   Jonker, Margreet ^c   Wubben, Jacqueline ^c   Doxiadis, Gaby ^c   Bontrop, Ronald ^c   Burlingham, William J ^b,d   Knechtle, Stuart J ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^d G4/702 CSC ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10 ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE GRAFT REJECTION; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE MODEL; HISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION TOLERANCE;

EID: 11144357341     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.9.5753     Document Type: Article

References (50)

1. Lafferty, K. J., S. K. Babcock, and R. G. Gill. 1986. Prevention of rejection by treatment of the graft: an overview. Prog. Clin. Biol. Res. 224:87.
2. Niederkorn, J. Y., E. Mayhew, and Y. He. 1995. Alloantigens introduced into the anterior chamber of the eye induce systemic suppression of delayed hypersensitivity to third-party alloantigens through "linked recognition." Transplantation 60:348.
3. VanBuskirk, A. M., M. E. Wakely, J. H. Sirak, and C. G. Orosz. 1998. Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity. Transplantation 65:1115.
4. Bickerstaff, A. A., A. M. VanBuskirk, E. Wakely, and C. G. Orosz. 2000. Transforming growth factor-β and interleukin-10 subvert alloreactive delayed type hypersensitivity in cardiac allograft acceptor mice. Transplantation 69:1517.
5. VanBuskirk, A. M., W. J. Burlingham, E. Jankowska-Gan, T. Chin, S. Kusaka, F. Geissler, R. P. Pelletier, and C. G. Orosz. 2000. Human allograft acceptance is associated with immune regulation. J. Clin. Invest. 106:145.
6. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151.
7. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194:629.
8. Hara, M., C. I. Kingsley, M. Niimi, S. Read, S. E. Turvey, A. R. Bushell, P. J. Morris, F. Powrie, and K. J. Wood. 2001. Il-10 is required for regulatory t cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166:3789.
9. + suppressor cell and its mechanisms of action. J. Exp. Med. 171:141.
10. high regulatory cells in human peripheral blood. J. Immunol. 167:1245.
11. + human thymocytes. J. Exp. Med. 196:379.
12. + suppressor T cells. J. Exp. Med. 193:F41.
13. high-induced colitis by a TGF-β-dependent mechanism. J. Immunol. 170:2516.
14. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196:237.
15. Knechtle, S. J., J. H. Fechner, Jr., Y. Dong, S. Stavrou, D. M. Neville, Jr., T. Oberley, P. Buckley, N. Armstrong, K. Rusterholz, X. Hong, et al. 1998. Primate renal transplants using immunotoxin. Surgery 124:438.
16. Fechner, J. H., Jr., Y. Dong, X. Hong, K. G. Brunner, M. Tsuchida, D. Neville, J. Scharff, F. Lee, T. D. Oberley, D. Peters, et al. 2001. Graft survival in a rhesus renal transplant model after immunotoxin-mediated T-cell depletion is enhanced by mycophenolate and steroids. Transplantation 72:581.
17. Leonard, A. A., M. Jonker, and E. L. Lagaaij. 1996. Complete withdrawal of immunosuppression in allograft recipients: a study in rhesus monkeys. Transplantation 61:1648.
18. Jonker, M., J. Ringers, M. A. Ossevoort, W. Slingerland, Y. van den Hout, K. Haanstra, J. Wubben, E. Kuhn, P. Friend, and R. Calne. 2002. Long-term kidney graft survival by delayed T cell ablative treatment in rhesus monkeys. Transplantation 73:874.
19. Cho, C. S., L. C. Burkly, J. H. Fechner, Jr., A. D. Kirk, T. D. Oberley, Y. Dong, K. G. Brunner, D. Peters, C. N. TenHoor, K. Nadeau, et al. 2001. Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients. Transplantation 72:587.
20. Knechtle, S. J., D. Vargo, J. Fechner, Y. Zhai, J. Wang, M. J. Hanaway, J. Scharff, H. Hu, L. Knapp, D. Watkins, et al. 1997. FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation 63:1.
21. Knapp, L. A., L. F. Cadavid, M. E. Eberle, S. J. Knechtle, R. E. Bontrop, and D. I. Watkins. 1997. Identification of new mamu-DRB alleles using DGGE and direct sequencing. Immunogenetics 45:171.
22. Doxiadis, G. G., N. Otting, N. G. de Groot, R. Noort, and R. E. Bontrop. 2000. Unprecedented polymorphism of Mhc-DRB region configurations in rhesus macaques. J. Immunol. 164:3193.
23. Racusen, L. C., K. Solez, R. B. Colvin, S. M. Bonsib, M. C. Castro, T. Cavallo, B. P. Croker, A. J. Demetris, C. B. Drachenberg, A. B. Fogo, et al. 1999. The Banff 97 working classification of renal allograft pathology. Kidney Int. 55:713.
24. Giambartolomei, G. H., V. A. Dennis, and M. T. Philipp. 1998. Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys. Infect. Immun. 66:2691.
25. Hamawy, M. M., M. Tsuchida, E. R. Manthei, and S. J. Knechtle. 2000. Detection of cells recognizing donor graft-derived fibroblasts in the blood of allograft-rejecting animals. Transplantation 69:S152 (Abstr.).
26. Carrodeguas, L., C. G. Orosz, W. J. Waldman, D. D. Sedmak, P. W. Adams, and A. M. VanBuskirk. 1999. Trans vivo analysis of human delayed-type hypersensitivity reactivity. Hum. Immunol. 60:640.
27. Taylor, C. R., S. R. Shi, C. Chen, L. Young, C. Yang, and R. J. Cote. 1996. Comparative study of antigen retrieval heating methods: microwave, microwave and pressure cooker, autoclave, and steamer. Biotech. Histochem. 71:263.
28. Annes, J. P., J. S. Munger, and D. B. Rifkin. 2003. Making sense of latent TGFβ activation. J. Cell Sci. 116:217.
29. Nishimura, N., M. Harada-Shiba, S. Tajima, R. Sugano, T. Yamamura, Q. Z. Qiang, and A. Yamamoto. 1998. Acquisition of secretion of transforming growth factor-β1 leads to autonomous suppression of scavenger receptor activity in a monocyte-macrophage cell line, THP-1. J. Biol. Chem. 273:1562.
30. Jain, S., P. N. Furness, and M. L. Nicholson. 2000. The role of transforming growth factor β in chronic renal allograft nephropathy. Transplantation 69:1759.
31. Gaedeke, J., H. Peters, N. A. Noble, and W. A. Border. 2001. Angiotensin II, TGF-β and renal fibrosis. Contrib. Nephrol. 153.
32. + T cells, transforming growth factor β1 expression and rejection grade. Transplantation 71:306.
33. + CTL accumulate within the graft epithelium during clinical renal allograft rejection. Transplantation 72:1548.
34. Burlingham, W., S. Kusaka, L. Chin, D. Hullett, S. Knechtle, H. Sollinger, T. Oberley, J. Pirsch, A. Kirk, and B. Becker. 1999. Focal infiltrates in kidney allografts: developing a model for clinical transplant peripheral tolerance. Graft 2:253.
35. Josien, R., P. Douillard, C. Guillot, M. Muschen, I. Anegon, J. Chetritt, S. Menoret, C. Vignes, J. P. Soulillou, and M. C. Cuturi. 1998. A critical role for transforming growth factor-β in donor transfusion-induced allograft tolerance. J. Clin. Invest. 102:1920.
36. Burlingham, W. J., P. J. O'Connell, L. M. Jacobson, B. N. Becker, A. D. Kirk, V. Pravica, and I. V. Hutchinson. 2000. Tumor necrosis factor-α and tumor growth factor-β1 genotype: partial association with intragraft gene expression in two cases of long-term peripheral tolerance to a kidney transplant. Transplantation 69:1527.
37. Shi, W. K., Q. W. Ye, and L. P. Bao. 1993. Biological characterization of a monoclonal antibody TB 21 against human transforming growth factor-β1. Shi Yan Sheng Wu Xue Bao 26:141.
38. Crawford, S. E., V. Stellmach, J. E. Murphy-Ullrich, S. M. Ribeiro, J. Lawler, R. O. Hynes, G. P. Boivin, and N. Bouck. 1998. Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 93:1159.
39. Yehualaeshet, T., R. O'Connor, J. Green-Johnson, S. Mai, R. Silverstein, J. E. Murphy-Ullrich, and N. Khalil. 1999. Activation of rat alveolar macrophage-derived latent transforming growth factor β-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am. J. Pathol. 155:841.
40. Young, K. J., L. Yang, M. J. Phillips, and L. Zhang. 2002. Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells. Blood 100:3408.
41. Juedes, A. E., and M. G. Von Herrath. 2003. Using regulatory APCs to induce/maintain tolerance. Ann. NY Acad. Sci. 1005:128.
42. Mahnke, K., J. Knop, and A. H. Enk. 2003. Induction of tolerogenic DCs: "you are what you eat." Trends Immunol. 24:646.
43. Imamura, M., and J. Tanaka. 2003. Immunoregulatory cells for transplantation tolerance and graft-versus-leukemia effect, Int. J. Hematol. 78:188.
44. Belghith, M., J. A. Bluestone, S. Barriot, J. Megret, J. F. Bach, and L. Chatenoud. 2003. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med 9:1202.
45. Yamada, A., A. Chandraker, T. M. Laufer, A. J. Gerth, M. H. Sayegh, and H. Auchincloss, Jr. 2001. Recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade. J. Immunol. 167:5522.
46. Rodriguez, D. S., E. Jankowska-Gan, L. D. Haynes, G. Leverson, A. Munoz, D. M. Heisey, H. W. Sollinger, and W. J. Burlingham. 2004. Immune regulation and graft survival in kidney transplant recipients are both enhanced by HLA matching. Am. J. Transplantation. In press.
47. Graca, L., S. P. Cobbold, and H. Waldmann. 2002. Identification of regulatory T cells in tolerated allografts. J. Exp. Med. 195:1641.
48. Bickerstaff, A. A., J. J. Wang, R. P. Pelletier, and C. G. Orosz. 2001. Murine renal allografts: spontaneous acceptance is associated with regulated T cell-mediated immunity. J. Immunol. 167:4821.
49. Niederkorn, J. Y., and J. W. Streilein. 1983. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses. J. Immunol. 131:2670.
50. Katagiri, K., J. Zhang-Hoover, J. S. Mo, J. Stein-Streilein, and J. W. Streilein. 2002. Using tolerance induced via the anterior chamber of the eye to inhibit Th2-dependent pulmonary pathology. J. Immunol. 169:84.